Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,225 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07304518RecruitingPhase 2
PRT-064040 nasal spray for migraine in adults
This trial tests a new nasal spray, PRT-064040, to see if it can help treat migraine attacks. It is for adults who have had migraines for at least a year and get 2 to 8 moderate to severe migraines per month.
Beijing, Beijing MunicipalityAges 18–75 - NCT07305259RecruitingEarly Phase 1
Exercise as a cancer therapy aid
This study tests whether adding exercise to cancer treatment can help people. It's for people who are physically fit and don't have other health conditions or take certain medications.
Tallahassee, FloridaAges 18–45 - NCT07305974RecruitingPhase 2
Study of RG002C0106 for primary IgA nephropathy
This phase 2a trial tests an experimental drug called RG002C0106 in people with primary IgA nephropathy. The goal is to see if the drug can reduce protein in the urine and protect kidney function.
Beijing, Beijing MunicipalityAges 18–65 - NCT07306754RecruitingPhase 1
A Safety Study of ABBV-243 in Healthy Adults
This study tests a new drug called ABBV-243 in healthy adults to see if it is safe and how the body processes it. Participation helps researchers understand the drug before studying it in people with a disease.
Grayslake, IllinoisAges 18–60 - NCT07307417Recruiting
Breathing muscle training for obesity
This trial tests if training your breathing muscles can improve respiratory function in people with obesity. It aims to help those with a BMI of 30 or higher.
Wroclaw, Dolny ŚląskAges 30–60 - NCT07308756RecruitingPhase 4
Study on two drugs for better recovery after surgery
This trial tests if giving two medicines, dexmedetomidine and esketamine, during and after surgery can help you feel better and recover more comfortably. It is for adults having general anesthesia for at least one hour who will use a patient-controlled pain pump afterward.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07309432RecruitingPhase 3
Birch allergy shot study for eye symptoms
This trial tests a new antibody treatment for eye allergy symptoms caused by birch pollen. It may help if you have severe eye allergies during birch season.
Andover, MassachusettsAges 12 years+ - NCT07309614RecruitingPhase 3
Dupilumab for asthma remission study
This trial tests whether dupilumab can help people with moderate-to-severe asthma achieve clinical remission. It may be an option if you have asthma with high levels of certain inflammatory markers and have had at least one asthma attack in the last 2 years.
Nedlands, Western AustraliaAges 18–79 - NCT07310264RecruitingPhase 1
Safety study of a new drug for Parkinson's disease
This trial tests a new drug called VT-5006 to see if it is safe for people with Parkinson's disease. It focuses on those who have stomach or bowel issues, like constipation.
LeidenAges 18–80 - NCT07311395Recruiting
Gentamicin injection to prevent infection after planned C-section
This study tests whether a local injection of gentamicin, an antibiotic, into the incision area can help prevent infections after a planned C-section. It may offer extra protection beyond standard antibiotics.
NahariyaAges 18 years+ - NCT07311512Recruiting
Gum treatment and mouthwash study for gum disease
This trial tests if a professional gum cleaning combined with a special mouthwash can improve gum health and blood vessel function. It may help people with early gum disease who haven't had recent gum treatment.
Portsmouth, HampshireAges 30–75 - NCT07311564RecruitingPhase 2
Study of LAD603 for adults with severe alopecia areata
This trial tests a new medication called LAD603 for people with severe to very severe alopecia areata, a condition causing significant hair loss. It aims to see if the drug can help regrow hair.
Omaha, NebraskaAges 18–65 - NCT07312110RecruitingPhase 2
D-Serine for slowing Parkinson's disease progression
This study tests whether a supplement called D-serine can slow the progression of Parkinson's disease. It is for people diagnosed within the last 5 years who have mild to moderate symptoms and are not yet dependent on a wheelchair.
Arendal, AgderAges 40–80 - NCT07313722RecruitingPhase 1
Testing a new eye drop for safety in healthy volunteers
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
ShanghaiAges 18–50 - NCT07314359Recruiting
Study of a biofield patch on antioxidants and energy
This study tests a special patch (called a biofield patch) to see if it can improve your body's antioxidant levels and energy. It involves several clinic visits with blood draws over a short time period.
Klamath Falls, OregonAges 18–75 - NCT07315061RecruitingPhase 2
Testing D-2570 for active psoriatic arthritis
This trial tests an oral medication, D-2570, for people with active psoriatic arthritis. It aims to see if the drug can reduce joint pain and swelling.
Chengdu, SichuanAges 18–70 - NCT07315516RecruitingPhase 2
Sleep and stress supplement study
This study tests a new supplement to help with sleep and stress. It is for adults who feel stressed and have sleep problems, but are otherwise healthy.
BrisbaneAges 18 years+ - NCT07316296RecruitingPhase 3
Testing a drug to reduce freezing of gait in Parkinson's
This trial tests whether atomoxetine, a drug that boosts a brain chemical called noradrenaline, can help reduce freezing of gait—a feeling of your feet being stuck to the ground—in people with Parkinson's disease. You would continue your usual Parkinson's medications during the study and undergo walking tests and brain scans to see if the drug helps.
Nijmegen, GelderlandAges 18 years+ - NCT07318129Recruiting
Indole-3-propionic acid for multiple sclerosis
This trial tests an oral supplement called indole-3-propionic acid to see if it can help people with relapsing-remitting multiple sclerosis (RRMS). It involves taking the supplement daily and having regular MRI scans to monitor your MS.
Glostrup MunicipalityAges 18–65 - NCT07318675RecruitingPhase 1
Testing an ointment for actinic keratosis on the face
This trial tests an ointment called HW211026 for people with actinic keratosis, a common skin condition caused by sun damage. The study will check if the ointment is safe and works when applied to a 10 cm by 10 cm area on the face.
ShanghaiAges 18 years+ - NCT07318896Recruiting
Agar and collagen supplement study for knee pain
This trial tests whether a supplement made from agar and collagen can help reduce knee pain in people with mild to moderate osteoarthritis. If you are between 40 and 70 and have knee pain, this may be an option for you.
Reus, TarragonaAges 40–70 - NCT07319117Recruiting
Can a nutritional drink help your brain under stress?
This study tests whether a special nutritional drink can help your brain work better when you're under stress. If you're a healthy woman in her 40s or 50s who drinks coffee daily, you may be able to join.
Leeds, West YorkshireAges 40–60 - NCT07319598RecruitingPhase 4
Tetrandrine tablets for connective tissue disease-related lung disease
This study tests if tetrandrine tablets can help people with lung disease caused by connective tissue disorders. It is for adults 18-80 who have stable treatment and meet specific health criteria.
BeijingAges 18–80 - NCT07320625RecruitingPhase 3
Montelukast for heart attack patients getting emergency artery opening
This trial tests if montelukast, a medicine used for asthma, can help people having a certain type of heart attack (anterior STEMI) recover better. You may qualify if you are having this heart attack and getting a procedure to open the artery within 12 hours.
Dalian, LiaoningAges 18–75
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,225 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.